Peter*, a 38-year-old retail marketing manager in Brooklyn, New York, is now six months post-op from a hair transplant. He ...

Several medications now calm painful inflammation in the intestines. Diets free of ultraprocessed foods also help ...

Treatment with inebilizumab was associated with continued improvement in patients with AChR+ generalized myasthenia gravis, according to 52-week results from the MINT trial.

b During this visit, the patient was prescribed prednisone 10 mg orally daily and his warfarin dosage was decreased to 9 mg weekly. c During this visit, the patient’s warfarin dosage was ...

Discover the causes behind fatty liver disease, a condition affecting 25% of adults worldwide, and learn simple lifestyle ...

Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...

In a live event, Ganesh V. Raj, MD, PhD, discussed the drug-drug interactions and outcomes by disease volumes across ARPI trials in mHSPC.

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

The patient’s own doctors couldn’t agree on a cause. One said asthma. Another implicated her age, then 71. A third blamed ...

Trial for this rare genetic disease to be conducted by NIH/NIAID in partnership with Corvus ITK inhibition intended to address dysregulation of T cells that causes ALPS and has been shown to be ...